These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1666353)

  • 1. Assessment of standardized ultrafiltrate production rate using prostacyclin in continuous venovenous hemofiltration.
    Journois D; Chanu D; Pouard P; Mauriat P; Safran D
    Contrib Nephrol; 1991; 93():202-4. PubMed ID: 1666353
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of prostacyclin as the only anticoagulant during continuous venovenous hemofiltration.
    Ponikvar R; Kandus A; Buturović J; Kveder R
    Contrib Nephrol; 1991; 93():218-20. PubMed ID: 1802584
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of prostacyclin in patients with continuous hemofiltration after open heart surgery.
    Klotz KF; Gellersen H; Brzelinski T; Sedemund-Adib B; Gehring H
    Contrib Nephrol; 1995; 116():136-9. PubMed ID: 8529366
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of prostacyclin on platelets, polymorphonuclear cells, and heterotypic cell aggregation during hemofiltration.
    Kozek-Langenecker SA; Spiss CK; Michalek-Sauberer A; Felfernig M; Zimpfer M
    Crit Care Med; 2003 Mar; 31(3):864-8. PubMed ID: 12626998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulation in continuous renal replacement therapy.
    Abramson S; Niles JL
    Curr Opin Nephrol Hypertens; 1999 Nov; 8(6):701-7. PubMed ID: 10630816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of the antithrombotic effects of heparin, enoxaparin and prostacycline in continuous hemofiltration].
    Journois D; Safran D; Castelain MH; Chanu D; Drévillon C; Barrier G
    Ann Fr Anesth Reanim; 1990; 9(4):331-7. PubMed ID: 2169213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombotic management with a stable prostacyclin analogue during extracorporeal circulation.
    Maurin N
    Contrib Nephrol; 1991; 93():205-9. PubMed ID: 1802582
    [No Abstract]   [Full Text] [Related]  

  • 8. A controlled trial of low-molecular-weight heparin (dalteparin) versus unfractionated heparin as anticoagulant during continuous venovenous hemodialysis with filtration.
    Reeves JH; Cumming AR; Gallagher L; O'Brien JL; Santamaria JD
    Crit Care Med; 1999 Oct; 27(10):2224-8. PubMed ID: 10548211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin-induced thrombocytopenia during continuous haemofiltration.
    Samuelsson O; Amiral J; Attman PO; Bennegård K; Björck S; Larsson G; Tengborn L
    Nephrol Dial Transplant; 1995; 10(9):1768-71. PubMed ID: 8559505
    [No Abstract]   [Full Text] [Related]  

  • 10. Anticoagulation with prostacyclin and heparin during continuous venovenous hemofiltration.
    Langenecker SA; Felfernig M; Werba A; Mueller CM; Chiari A; Zimpfer M
    Crit Care Med; 1994 Nov; 22(11):1774-81. PubMed ID: 7956281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin and prostacyclin in hemofiltration after orthotopic liver transplantation.
    Legat K; Zimpfer M; Steltzer H; Gabriel A; Müller C; Tüchy GL
    Transplant Proc; 1991 Jun; 23(3):1984. PubMed ID: 2063461
    [No Abstract]   [Full Text] [Related]  

  • 12. Coagulation, Fibrinolysis and Inhibitors in Failing Filters during Continuous Venovenous Hemofiltration in Critically Ill Patients with Acute Kidney Injury: Effect of Anticoagulation Modalities.
    Schilder L; Nurmohamed SA; ter Wee PM; Paauw NJ; Girbes AR; Beishuizen A; Beelen RH; Groeneveld AB
    Blood Purif; 2015; 39(4):297-305. PubMed ID: 25966765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the use of standard heparin and prostacyclin anticoagulation in spontaneous and pump-driven extracorporeal circuits in patients with combined acute renal and hepatic failure.
    Davenport A; Will EJ; Davison AM
    Nephron; 1994; 66(4):431-7. PubMed ID: 8015647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulation for continuous arteriovenous hemofiltration in children.
    Zobel G; Trop M; Muntean W; Ring E; Gleispach H
    Blood Purif; 1988; 6(2):90-5. PubMed ID: 3293620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of continuous venovenous hemofiltration with dialysis on hormone and catecholamine clearance in critically ill patients with acute renal failure.
    Bellomo R; McGrath B; Boyce N
    Crit Care Med; 1994 May; 22(5):833-7. PubMed ID: 8181293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute thrombogenicity of arterial prostheses exposed to reduced blood flow in dogs: effects of heparin, aspirin, and prostacyclin.
    Merhi Y; Bernier J; Marois Y; Guidoin R
    J Cardiovasc Pharmacol; 1995 Jul; 26(1):1-5. PubMed ID: 7564348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of continuous venovenous hemofiltration on neutrophil gelatinase-associated lipocalin plasma levels in patients with septic acute kidney injury.
    Dai X; Li T; Zeng Z; Fu C; Wang S; Cai Y; Chen Z
    BMC Nephrol; 2016 Oct; 17(1):154. PubMed ID: 27760529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal replacement therapies.
    Meyer MM
    Crit Care Clin; 2000 Jan; 16(1):29-58, v. PubMed ID: 10650499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of anticoagulation with heparin versus heparin plus epoprostenol in patients undergoing extracorporeal liver support with Prometheus.
    Krisper P; Tiran B; Fliser D; Haditsch B; Stadlbauer V; Otto R; Ernst T; Kretschmer U; Stauber RE; Haller H; Holzer H; Manns MP; Rifai K
    Artif Organs; 2010 Jan; 34(1):84-8. PubMed ID: 19663866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous Venovenous Hemofiltration in Children Less Than or Equal to 10 kg: A Single-Center Experience.
    Kaempfen S; Dutta-Kukreja P; Mok Q
    Pediatr Crit Care Med; 2017 Feb; 18(2):e70-e76. PubMed ID: 27977538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.